Rose Jed E
Center for Nicotine and Smoking Cessation Research, Duke University Medical Center, Durham, NC 27705, USA.
Biochem Pharmacol. 2007 Oct 15;74(8):1263-70. doi: 10.1016/j.bcp.2007.07.039. Epub 2007 Aug 3.
Over the last 20 years much progress has been made in understanding the pharmacologic basis of tobacco addiction. In particular, the role of nicotine in reinforcing smoking behavior has been studied from a variety of perspectives. This article discusses two important aspects of this topic: (1) brain pathways underlying tobacco addiction; and (2) the actions of nicotine at nicotinic cholinergic receptors. Recent evidence will be reviewed indicating that nicotine reinforces smoking behavior by acting on more than one subtype of nicotinic receptor. Similarly, the role of several brain pathways in tobacco addiction will be considered. Tobacco addiction may thus be seen as a complex neuropsychopharmacological disorder; further progress in smoking cessation treatment may require that we address the multiple molecular and brain components of this addiction.
在过去20年里,在理解烟草成瘾的药理学基础方面取得了很大进展。特别是,已经从各种角度研究了尼古丁在强化吸烟行为中的作用。本文讨论了该主题的两个重要方面:(1)烟草成瘾背后的脑通路;(2)尼古丁在烟碱型胆碱能受体上的作用。将综述最近的证据,表明尼古丁通过作用于不止一种烟碱型受体亚型来强化吸烟行为。同样,将考虑几种脑通路在烟草成瘾中的作用。因此,烟草成瘾可被视为一种复杂的神经精神药理学障碍;戒烟治疗的进一步进展可能需要我们解决这种成瘾的多个分子和脑组成部分。